Regal Investment Advisors LLC Gilead Sciences, Inc. Transaction History

Regal Investment Advisors LLC

$1.4 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $9,891 - $11,217	-135 Reduced 3.42%	3,818 $309,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $4,880 - $5,324	66 Added 1.7%	3,953 $296,000
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $608 - $693	-8 Reduced 0.21%	3,887 $299,000
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $21,414 - $24,398	277 Added 7.66%	3,895 $323,000
Q4 2022 Mar 01, 2023	SELL	$62.32 - $89.47 $1.16 Million - $1.67 Million	-18,638 Reduced 83.74%	3,618 $310,000
Q3 2022 Nov 15, 2022	BUY	$59.54 - $68.01 $27,447 - $31,352	461 Added 2.12%	22,256 $1.37 Million
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $33,535 - $37,770	-581 Reduced 2.6%	21,795 $1.35 Million
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $73,152 - $91,668	1,263 Added 5.98%	22,376 $1.33 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $237,525 - $269,596	3,661 Added 20.98%	21,113 $1.53 Million
Q3 2021 Nov 05, 2021	BUY	$67.69 - $73.03 $232,312 - $250,638	3,432 Added 24.48%	17,452 $1.22 Million
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $889,849 - $972,286	14,020 New	14,020 $965,000
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $1.03 Million - $1.18 Million	-17,220 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $975,513 - $1.11 Million	17,220 New	17,220 $1 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $1.22 Million - $1.54 Million	-19,673 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$72.34 - $84.0 $1.42 Million - $1.65 Million	19,673 New	19,673 $1.51 Million
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $1.84 Million - $2.36 Million	-29,373 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$61.62 - $67.78 $26,681 - $29,348	-433 Reduced 1.45%	29,373 $1.91 Million
Q3 2019 Nov 15, 2019	BUY	$62.51 - $69.0 $1.86 Million - $2.06 Million	29,806 New	29,806 $1.89 Million
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $187,976 - $245,295	-3,105 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$71.28 - $78.92 $221,324 - $245,046	3,105 New	3,105 $240,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $176,408 - $205,773	-2,719 Closed	0 $0
Q1 2018 Apr 25, 2018	BUY	$72.84 - $88.8 $198,051 - $241,447	2,719 New	2,719 $205,000
Q4 2017 Feb 06, 2018	SELL	$71.15 - $83.52 $209,536 - $245,966	-2,945 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $212,363 - $251,709	2,945	2,945 $239,000

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.

Account